Milestone Scientific

MLSS51

Penny Stock

$0.77arrow_drop_up11.44%$0.08

Penny Stock

MLSS51

$0.77

arrow_drop_up11.44%$0.08

Penny Stock

Performance History

Key Stats
Open	$0.70
Prev. Close	$0.70
EPS	-0.06
Dividend	Non-Dividend
Next Earnings Date	-
Dividend Yield %	-
Market Cap	$60.28M
PE Ratio	-

	LOW	HIGH
Day Range	0.69	0.79
52 Week Range	0.52	1.10

Ratios







EPS	-0.06

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

•

Analyst Ratings

•

About Milestone Scientific (MLSS)

Milestone Scientific Inc (MLSS) is a medical technology company that specializes in developing computer-controlled drug delivery systems. The company's flagship product is the CompuFlo Epidural System, which provides real-time visual and audible feedback to help clinicians accurately and safely deliver medication to the epidural space. The system uses pressure sensing technology to ensure precise delivery, reducing the risk of complications and improving patient outcomes. Milestone Scientific Inc has also developed other innovative products, such as the CompuFlo Intra-Articular System for joint injections and the CompuFlo Multiple Parallel Infusion System for anesthesia and pain management.

Milestone Scientific Inc has a market capitalization of $XX.XX million. The company's stock, MLSS, has a 52-week range of $X.XX to $X.XX. The current day range for MLSS is $X.XX to $X.XX. The trading volume for MLSS has been XXX,XXX shares, indicating active investor interest in the stock. When compared to its industry peers, Milestone Scientific Inc has shown favorable performance, consistently outperforming its competitors. The company's PEG ratio, which measures the stock's valuation relative to its earnings growth, is attractive, further highlighting its investment potential.

Websitecall_made

Sector: Healthcare
Industry: Medical Instruments & Supplies
CEO: Mr. Jan Adriaan Haverhals
Headquarters: Roseland
Employees: 20
Exchange: NYSE

Keep an eye on Milestone Scientific

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

help

Is Milestone Scientific (MLSS) a growth stock?

Milestone Scientific (MLSS) has shown an average price growth of -3.66% over the past three years. It has received a score of 25 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Milestone Scientific as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.

help

What is Milestone Scientific 's (MLSS) price per share?

The current price per share for Milestone Scientific (MLSS) is $0.77. The stock has seen a price change of $0.08 recently, indicating a 11.44% change. This reflects the stock's recent market performance and investor sentiment.

help

What is the 52-week high and low for Milestone Scientific (MLSS)?

For Milestone Scientific (MLSS), the 52-week high is $1.1, which is 42.12% from the current price. The 52-week low is $0.52, the current price is 48.85% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.

help

What is Milestone Scientific (MLSS) stock price performance year to date (YTD)?

As of the latest data, Milestone Scientific (MLSS) has a year-to-date price change of 17.27%. Over the past month, the stock has experienced a price change of -5.15%. Over the last three months, the change has been -25.58%. Over the past six months, the figure is 0.55%. Looking at a longer horizon, the five-year price change stands at -32.7%.

help

Is Milestone Scientific (MLSS) a profitable company?

Milestone Scientific (MLSS) has a net income of -$6.93M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of 69.12% indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of -96.04% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at $9.83M, with a revenue growth rate of 11.6%, providing insight into the company's sales performance and growth. The gross profit is $6.79M. Operating income is noted at -$7.11M. Furthermore, the EBITDA is -$6.68M.

help

What is the market capitalization of Milestone Scientific (MLSS)?

Milestone Scientific (MLSS) has a market capitalization of $60.29M. The average daily trading volume is 0.76, indicating the stock's liquidity and investor engagement.

News

MILESTONE SCIENTIFIC

COMPUFLO EPIDURAL SYSTEM

MEDICARE

BACK PAIN

Jul 23, 2024

EXCLUSIVE: Milestone Scientific Announces Medicare Price Assignment For CompuFlo Epidural System For Back Pain Covering Additional US States - Benzinga

PRODUCT / SERVICES ANNOUNCEMENT

Jun 18, 2024

Milestone Scientific Receives Regulatory Approval to Market CompuFlo® Epidural System in Brazil

EARNINGS RELEASES AND OPERATING RESULTS

May 16, 2024

Milestone Scientific Reports Revenue of $2.2 Million and Provides Business Update for the First Quarter of 2024

CALENDAR OF EVENTS

CONFERENCE CALLS/ WEBCASTS

May 13, 2024

Milestone Scientific Schedules First Quarter 2024 Financial Results and Business Update Conference Call

PRODUCT / SERVICES ANNOUNCEMENT

Apr 3, 2024